Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Flex Pharma, Inc.

TRADE

NASDAQ: FLKSHealthcare / Biotechnology / USA
0.48+0.01+2.13%Vol 808 7781Y Perf -88.00%
Nov 14th, 2018 14:21
BID0.48 ASK0.48
Open0.46 Previous Close0.47
Pre-Market0.45 After-Trading-
 -0.02 -4.26%  - -%
Target Price
1.00 
Analyst Rating
Hold 3.00
Potencial %
108.33 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)9 
Earnings Rating
Price Range Ratio 52wk %
1.05 
Earnings Date

Today's Price Range

0.460.51

 

52wk Range

0.398.98

Summary:

Neutral

Technical Indicators: Strong Buy
Moving Averages: Sell
Performance
1 Month
-11.32%
3 Months
-20.34%
6 Months
-87.43%
1 Year
-88.00%
3 Years
-95.74%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
FLKS0.480.01002.13
AAPL187.52-4.7100-2.45
GOOG1 043.697.64000.74
MSFT105.56-1.3800-1.29
XOM77.23-0.7700-0.99
WFC52.06-0.6800-1.29
JNJ144.47-0.2100-0.15
FB143.631.47001.03
GE8.34-0.2700-3.14
JPM107.16-2.4300-2.22
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 4.50
Current Ratio 4.70
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin48.90
EBIT Margin-2 938.30
EBITDA Margin-2 912.10
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 0.84
PS Ratios 9.81
Price to Cash Flow -
Price to Free Cash Flow -0.40
Cash Flow Per Share -1.46
Price to Tangible Book0.84
Book Value per Share0.61
Enterprise Value (in ths.)-3 666
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-
ROE last 12 Months -118.32
Return on Assets (5Y Avg) -
ROA last 12 Months -101.34
Return on Capital (5Y Avg) -
ROC last 12 Months -118.32
Return on invested Capital Q -21.57
Return on invested Capital Y-77.88
Assets Turnover0.00
Receivables Turnover15.50
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)948
Revenue per Share 0.05
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2018--0.15-
Q02 2018-0.39-0.50-28.21
Q01 2018-0.50-0.468.00
Q04 2017-0.56-0.4617.86
Q03 2017-0.62-0.5412.90
Q02 2017-0.63-0.5119.05
Q01 2017-0.63-0.4922.22
Q04 2016-0.84-0.4842.86
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.2526.47Positive
12/2018 QR-0.1361.76Positive
12/2018 FY-1.23-846.15Negative
12/2019 FY-0.5557.03Positive
Next Report Date5th Nov 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume808 778
Shares Outstanding (in ths.)18 070
Trades Count1 088
Dollar Volume363 200
Avg. Volume650 411
Avg. Weekly Volume828 015
Avg. Monthly Volume1 823 639
Avg. Quarterly Volume1 642 466

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

57%43%

Bearish Bullish

40%60%

Bearish Bullish

65%35%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
1 (100.00 %)
2 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Hold
3.00

There are no comments yet.

News

x